Page last updated: 2024-10-28

phenelzine and Ventricular Fibrillation

phenelzine has been researched along with Ventricular Fibrillation in 2 studies

Phenelzine: One of the MONOAMINE OXIDASE INHIBITORS used to treat DEPRESSION; PHOBIC DISORDERS; and PANIC.

Ventricular Fibrillation: A potentially lethal cardiac arrhythmia that is characterized by uncoordinated extremely rapid firing of electrical impulses (400-600/min) in HEART VENTRICLES. Such asynchronous ventricular quivering or fibrillation prevents any effective cardiac output and results in unconsciousness (SYNCOPE). It is one of the major electrocardiographic patterns seen with CARDIAC ARREST.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rabinowitz, SH1
Lown, B2
Lehnert, H1
Lombardi, F1
Raeder, EA1
Lorenzo, AV1
Verrier, RL1
Wurtman, RJ1

Other Studies

2 other studies available for phenelzine and Ventricular Fibrillation

ArticleYear
Central neurochemical factors related to serotonin metabolism and cardiac ventricular vulnerability for repetitive electrical activity.
    The American journal of cardiology, 1978, Volume: 41, Issue:3

    Topics: 5-Hydroxytryptophan; Animals; Blood Pressure; Carbidopa; Cardiac Complexes, Premature; Cardiac Pacin

1978
Increased release of brain serotonin reduces vulnerability to ventricular fibrillation in the cat.
    Journal of cardiovascular pharmacology, 1987, Volume: 10, Issue:4

    Topics: 3,4-Dihydroxyphenylacetic Acid; 5-Hydroxytryptophan; Animals; Blood Pressure; Carbidopa; Cats; Coron

1987